The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach

Despite tremendous progress being made in recent years, multiple myeloma (MM) remains a challenging disease. The laboratory plays a critical role in the overall management of patients. The diagnosis, prognosis, clinical monitoring and evaluation of the response are key moments in the clinical care p...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rafael Ríos-Tamayo, Noemí Puig, Macarena Algarín, José Luís García de Veas Silva, Nuno Barbosa, Cristina Encinas, José Ángel Hernández, Rafael Alonso, María Luisa Campos, Teresa Rodríguez, Alberto Leivas, María José Olivares, María José Sánchez, Bruno Paiva, Juan José Lahuerta, Joaquín Martínez-López
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	multiple myeloma (MM) heavy/light chain (HLC) assay Hevylite<sup>®</sup> diagnosis prognosis monitoring Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c4e255d0d4804062aa087d575fcc2f4c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach

Ejemplares similares